Partnerships: VisEn Medical & Olympus Corp.

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

VisEn Medical, a provider of fluorescence in vivo imaging technology for research and medicine applications, today announced that it has signed an exclusive distribution agreement with Olympus Corporation covering sales of the company's Fluorescence Molecular Tomography imaging systems and portfolio of in vivo near infrared fluorescence imaging probes in Asia (South Korea, Singapore, China and Taiwan). This agreement is an expansion of an exclusive distribution agreement between the two companies covering Japan, which began in September 2006.